Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
University of California, San Francisco
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Centre hospitalier de l'Université de Montréal (CHUM)
AstraZeneca
National Institutes of Health Clinical Center (CC)
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
Daiichi Sankyo
Daiichi Sankyo
University of Oklahoma
Mayo Clinic
Tempus AI
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Vall d'Hebron Institute of Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jules Bordet Institute
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
pharmaand GmbH
Seagen Inc.
University of Iowa
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC